Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cian HealthcareBOM:542678 49 Days Payable is 374.57 as of Mar. 2026, which is 97% above its 10-year median of 189.78. GuruFocus rates BOM:542678 with a GF Score™ of 49/100 and a GF Value™ of ₹82.33 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 925 Drug Manufacturers companies, Cian Healthcare ranks better than 94.59% on this metric.
The historical rank and industry rank for Cian Healthcare's Days Payable or its related term are showing as below:
BOM:542678'
s Days Payable Range Over the Past 10 Years
Min: 33.19 Med: 189.78 Max: 586.89
Current: 493.96
During the past 11 years, Cian Healthcare's highest Days Payable was 586.89. The lowest was 33.19. And the median was 189.78.
BOM:542678's Days Payable is ranked better than 94.59% of 925
companies
in the Drug Manufacturers industry
Industry Median: 89.27
vs BOM:542678: 493.96
Cian Healthcare's Days Payable
declined
from Mar. 2025 (681.74) to Mar. 2026 (374.57).
It may suggest that Cian Healthcareaccelerated paying its suppliers.
The historical data trend for Cian Healthcare's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542678 vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cian Healthcare's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cian Healthcare Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cian Healthcare's Days Payable distribution charts can be found below:
* The bar in red indicates where Cian Healthcare's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cian Healthcare's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cian Healthcare (BOM:542678) has a Days Payable of 374.57 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cian Healthcare and its competitors. This is 97% above median its historical median of 189.78. Over the past decade, Cian Healthcare's Days Payable has ranged from 33.19 to 586.89. According to the industry distribution chart, Cian Healthcare ranks #50 out of 925 companies in the Drug Manufacturers industry, placing it in the top 5.4%.
Is Cian Healthcare's Days Payable too high?
Cian Healthcare's current Days Payable of 374.57 is 97% above median its 10-year median of 189.78. Over the past 10 years, this metric has ranged from a low of 33.19 to a high of 586.89. The Drug Manufacturers industry median Days Payable is 89.27. Cian Healthcare's value of 374.57 is 319.6% above this industry median. Based on the distribution chart, Cian Healthcare ranks #50 out of 925 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Cian Healthcare has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cian Healthcare's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cian Healthcare ranks #50 out of 925 companies for Days Payable. This places Cian Healthcare in the top 5% of its industry — outperforming the majority of peers. The industry median Days Payable is 89.27. Cian Healthcare's value of 374.57 is 319.6% above this benchmark. Historically, Cian Healthcare's own Days Payable has ranged from 33.19 to 586.89 over the past decade. While the company's 10-year median is 189.78 vs. the industry median of 89.27, Cian Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 89.27, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cian Healthcare's current Days Payable of 374.57 is 319.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cian Healthcare and its competitors. For the Drug Manufacturers industry, the median Days Payable is 89.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cian Healthcare's current Days Payable is 374.57, which is 97% above median its own 10-year median of 189.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cian Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Cian Healthcare (BOM:542678) is currently considered Possible Value Trap. The stock's GF Value™ is ₹82.33, compared to a current price of ₹9.55 — trading 88.4% below its estimated fair value. The current Days Payable is 374.57, which is 97% above median its 10-year median of 189.78 and 319.6% above the Drug Manufacturers industry median of 89.27. Cian Healthcare's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cian Healthcare (BOM:542678), the current Days Payable is 374.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cian Healthcare (BOM:542678) Overvalued in 2026?
Based on GuruFocus' analysis, Cian Healthcare stock appears to be undervalued.
The current stock price of ₹9.55 is trading 88.4% below its estimated GF Value™ of ₹82.33.
GuruFocus considers Cian Healthcare to be Possible Value Trap.
Key valuation signals for BOM:542678:
Days Payable: 374.57 (97% above median its 10-year median of 189.78)
GF Value™: ₹82.33 vs. price of ₹9.55 (88.4% below fair value)
Industry Position: 319.6% above the Drug Manufacturers median (#50 of 925)
No single metric tells the full story. See the BOM:542678 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cian Healthcare Ltd is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products. The company manufactures multiple product lines, including tablets, capsules, soft gels, liquid orals, ointments/creams and sachets, and cosmetics. Its portfolio comprises gynecology, haematinic, cardio-diabetic, orthopedic, pediatric, dermacosmetic, antibiotic, CNS, vitamins, and nutrient products. The company operates in five sectors: Export, Government Supplies, Merchant Export, Own Brand Franchise Business, and Third Party/Contract Manufacturing.
49GF Score
Get the complete analysis for BOM:542678
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542678 has been successfully added to your 
